CompuGroup Medical SE & Co KgaA
CompuGroup Medical SE & Co's GHG Emissions Data Preview
In 2024, CompuGroup Medical SE & Co completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
CompuGroup Medical SE & Co has also provided a category-level breakdown for 8 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
a
a
a
a
a
a
a
aVerified Sources Behind CompuGroup Medical SE & Co’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CompuGroup Medical SE & Co’s data sources below and access millions more through our Disclosure Search.
Insights into CompuGroup Medical SE & Co's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of CompuGroup Medical SE & Co amounted to 18,391.27 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
CompuGroup Medical SE & Co's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are CompuGroup Medical SE & Co's Scope 1 emissions?
In 2024, the total Scope 1 emissions of CompuGroup Medical SE & Co were 12,751.08 metric tons of CO₂ equivalent (tCO₂e). a
What are CompuGroup Medical SE & Co's Scope 2 emissions?
In 2024, CompuGroup Medical SE & Co reported Scope 2 greenhouse gas (GHG) emissions of 11,647.62 tCO₂e using the market-based method and 5,640.19 tCO₂e using the location-based method. a
What methodology does CompuGroup Medical SE & Co use for Scope 2 reporting?
In 2024, CompuGroup Medical SE & Co reported its Scope 2 emissions using the market-based method and using the location-based method. a
CompuGroup Medical SE & Co's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into CompuGroup Medical SE & Co's Value Chain Emissions
In 2024, CompuGroup Medical SE & Co reported 289,311.45 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of CompuGroup Medical SE & Co includes a breakdown across 8 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in , reflecting improved emissions accounting practices and greater transparency across the company's value chain a
CompuGroup Medical SE & Co's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are CompuGroup Medical SE & Co's Scope 3 emissions?
In 2024, CompuGroup Medical SE & Co reported total Scope 3 emissions of 289,311.45 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 21.28% of these emissions originated from upstream activities such as purchased goods and capital goods, while 78.72% came from downstream activities like product use, distribution, and end-of-life treatment. a
What categories of Scope 3 emissions does CompuGroup Medical SE & Co disclose?
In 2024, CompuGroup Medical SE & Co reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of CompuGroup Medical SE & Co's Scope 3 emissions?
In 2024, the largest contributors to CompuGroup Medical SE & Co's Scope 3 emissions were: a
- Use of Sold Products (Cat. 11): 224,913.52 tCO₂e (77.74%)
- Purchased Goods and Services (Cat. 1): 32,917.33 tCO₂e (11.38%)
- Employee Commuting (Cat. 7): 16,253.86 tCO₂e (5.62%)
CompuGroup Medical SE & Co's Scope 3 Emissions by Categories
Insights into CompuGroup Medical SE & Co's Total Carbon Footprint
In 2024, CompuGroup Medical SE & Co reported a total carbon footprint of 307,702.72 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. a
The largest contributor to CompuGroup Medical SE & Co's total carbon footprint was Scope 3 emissions, accounting for 94.02% of the company's total carbon footprint, followed by Scope 1 emissions at 4.14%. a